Attached files
file | filename |
---|---|
EX-23.2 - EX-23.2 - Amneal Pharmaceuticals, Inc. | d414240dex232.htm |
S-1 - S-1 - Amneal Pharmaceuticals, Inc. | d414240ds1.htm |
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption Experts and to the use of our report dated March 7, 2018, in the Registration Statement (Form S-1) and related Prospectus of Atlas Holdings, Inc. for the registration of 226,738,335 shares of its Class A common stock.
/s/ Ernst & Young LLP
Iselin, New Jersey
March 7, 2018